Hans‐dieter Flad

Hans‐dieter Flad's AcademicInfluence.com Rankings

Hans‐dieter Flad

Philosophy

#9125

World Rank

#12635

Historical Rank

Logic

#6117

World Rank

#7600

Historical Rank

philosophy Degrees

Hans‐dieter Flad

Biology

#12470

World Rank

#15947

Historical Rank

Immunology

#833

World Rank

#856

Historical Rank

Molecular Biology

#2024

World Rank

#2056

Historical Rank

Biochemistry

#2125

World Rank

#2269

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Hans‐dieter Flad Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hans‐dieter Flad's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. (1991) (911)
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins (1993) (781)
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. (1996) (488)
New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. (1993) (413)
Heterogeneity of human peripheral blood monocyte subsets (2001) (377)
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. (2000) (302)
IL-1 induction-capacity of defined lipopolysaccharide partial structures. (1989) (258)
Nitric oxide synthase: MRNA expression of different isoforms in human monocytes/macrophages (1994) (229)
Biochemistry and cell biology of bacterial endotoxins. (1996) (213)
Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. (1979) (211)
The β‐thromboglobulins and platelet factor 4: blood platelet‐derived CXC chemokines with divergent roles in early neutrophil regulation (2000) (199)
Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. (1990) (197)
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures (1994) (189)
Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. (1990) (188)
Identification of a novel dendritic cell‐like subset of CD64+ / CD16+ blood monocytes (2001) (175)
Biochemical characterization of a factor released by macrophages. (1975) (173)
Platelet‐derived CXC chemokines: old players in new games (2000) (172)
Phenotypical and functional characterization of Fey receptor I (CD64)‐negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity (1993) (165)
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes (1997) (159)
The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. (1997) (150)
Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. (1997) (148)
Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes (1994) (140)
Mycobacteria-Induced TNF-α and IL-10 Formation by Human Macrophages Is Differentially Regulated at the Level of Mitogen-Activated Protein Kinase Activity1 (2001) (139)
Differential expression and function of CD80 (B7‐1) and CD86 (B7‐2) on human peripheral blood monocytes (1996) (136)
Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14 (1995) (135)
Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. (1998) (131)
Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1β* (1997) (129)
IL-8 specifically binds to endothelial but not to smooth muscle cells. (1995) (127)
Inhibition of HIV progression by dithiocarb (1990) (125)
Lipopolysaccharide‐binding protein mediates CD14‐independent intercalation of lipopolysaccharide into phospholipid membranes (1996) (124)
Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria (1996) (123)
Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. (1988) (120)
Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages. (1975) (119)
CD26 Antigen is a Surface Dipeptidyl Peptidase IV (DPPIV) as Characterized by Monoclonal Antibodies Clone Til‐19‐4‐7 and 4EL1C7 (1990) (118)
A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. (1998) (114)
Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. (1994) (112)
Induction of human interleukin 1 by bacterial and synthetic lipid A (1986) (111)
Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. (1984) (107)
PRODUCTION OF CYTOKINES (TNF‐ALPHA, IL‐1‐BETA) AND ENDOTHELIAL CELL ACTIVATION IN HUMAN LIVER ALLOGRAFT REJECTION1 (1993) (107)
Human follicular dendritic cells and vascular cells produce interleukin‐7: a potential role for interleukin‐7 in the germinal center reaction (1996) (104)
Platelet-Derived Chemokines CXC Chemokine Ligand (CXCL)7, Connective Tissue-Activating Peptide III, and CXCL4 Differentially Affect and Cross-Regulate Neutrophil Adhesion and Transendothelial Migration1 (2002) (99)
Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. (1991) (99)
Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. (1996) (98)
Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). (1994) (95)
TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. (1996) (94)
Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. (1998) (93)
Induction of proliferation and cytokine production in human T lymphocytes by lipopolysaccharide (LPS). (2000) (93)
Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. (1998) (89)
Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. (1994) (86)
Platelet-derived chemokines: pathophysiology and therapeutic aspects (2010) (85)
TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. (1999) (83)
Bacterial endotoxin: molecular relationships between structure and activity. (1991) (83)
Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8. (1999) (80)
Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects. (1994) (79)
Nitric oxide synthase: expression of the endothelial, Ca2+/calmodulin‐dependent isoform in human B and T lymphocytes (1996) (78)
Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. (1992) (75)
Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures. (1989) (75)
Chemical structure and biologic activity of bacterial and synthetic lipid A. (1987) (74)
Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. (1990) (74)
Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis (1996) (73)
Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells1 (2002) (73)
Control of Mycobacterial Replication in Human Macrophages: Roles of Extracellular Signal-Regulated Kinases 1 and 2 and p38 Mitogen-Activated Protein Kinase Pathways (2002) (73)
Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. (2000) (72)
Identification of Distinct Surface-Expressed and Intracellular CXC-Chemokine Receptor 2 Glycoforms in Neutrophils: N-Glycosylation Is Essential for Maintenance of Receptor Surface Expression1 (2000) (71)
Joint report of 1st International Workshop on Canine Immunogenetics. (1973) (70)
Agonists and antagonists for lipopolysaccharide-induced cytokines. (1993) (70)
Fas (CD95)-Fas Ligand Interactions Are Responsible for Monocyte Apoptosis Occurring as a Result of Phagocytosis and Killing of Staphylococcus aureus (2001) (69)
Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. (1993) (67)
Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IV. (1985) (67)
Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein (1995) (67)
Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon. (1993) (66)
The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. (2001) (64)
The role of fetal calf serum in the primary immune response in vitro (1977) (64)
Components of gut bacteria as immunomodulators. (1998) (64)
Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity. (1993) (63)
Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells (1995) (57)
Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. (1992) (56)
The human germinal centre cells, follicular dendritic cells and germinal centre T cells produce B cell-stimulating cytokines. (1995) (55)
Isolation of normal human follicular dendritic cells and CD4‐independent in vitro infection by human immunodeficiency virus (HIV‐1) (1991) (54)
Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors. (1987) (54)
The role of cytokines in monocyte apoptosis. (1998) (51)
Reduced T‐cell receptor CD3ζ‐chain protein and sustained CD3ε expression at the site of mycobacterial infection (2001) (51)
Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. (2000) (49)
Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells (1991) (49)
CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma. (1995) (49)
Tumor Necrosis Factor α and Lymphotoxin Production in Hodgkin's Disease (1990) (48)
The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system. (1999) (48)
Low In Vitro Production of Interferon-γ and Tumor Necrosis Factor-α in HIV-Seronegative Patients with Pulmonary Disease Caused by Nontuberculous Mycobacteria (2000) (48)
Increased IL‐10 production during spontaneous apoptosis of monocytes (2002) (48)
Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2. (1994) (48)
Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production (1994) (46)
Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. (1996) (45)
Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma. (1990) (45)
Cell proliferation-associated nuclear antigen defined by antibody Ki-67: a new kind of cell cycle-maintaining proteins. (1995) (45)
Dipeptidyl peptidase IV as a new surface marker for a subpopulation of human T-lymphocytes. (1984) (45)
Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein. (2000) (44)
Inhibitory and stimulatory effects of Pseudomonas aeruginosa pyocyanine on human T and B lymphocytes and human monocytes (1990) (43)
Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions. (1998) (43)
An improved method for the species‐specific assessment of mycobacteria in routinely formalin‐fixed and paraffin‐embedded tissues (1995) (42)
Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55). (1999) (42)
Bacillus-Calmette-Guérin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion. (1999) (42)
Treatment of aplastic anemia by blood stem cell transfusion: a canine model. (1976) (40)
Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures (1992) (40)
Detection of interleukin 1 with human dermal fibroblasts. (1989) (38)
Lipopolysaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. (1995) (36)
Impaired recirculation of b lymphocytes in chronic lymphocytic leukemia (1973) (36)
Human Vascular Smooth Muscle Cells Express Interleukin-1β–converting Enzyme (ICE), but Inhibit Processing of the Interleukin-1β Precursor by ICE (1997) (36)
Limited and Defined Truncation at the C Terminus Enhances Receptor Binding and Degranulation Activity of the Neutrophil-activating Peptide 2 (NAP-2) (1995) (35)
The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells (1995) (33)
Membrane dynamics of HL-A-anti-HL-A complexes of human normal and leukaemic lymphocytes. (1973) (33)
Molecular Aspects of the Chemistry and Biology of Endotoxin (1991) (32)
A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity. (1993) (31)
Altered antigen-presenting capacity of human monocytes after phagocytosis of bacteria (1994) (31)
Inhibition of HIV progression by dithiocarb. German DTC Study Group. (1990) (29)
Role of ADP-ribosylation in activated monocytes/macrophages. (1997) (29)
Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies. (1997) (28)
Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria. (2000) (26)
Expression of CD26 (Dipeptidyl Peptidase IV) on Memory and Naive T Lymphocytes (1992) (26)
Mycobacterial nucleic acids in sarcoid lesions. (1992) (26)
Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection. (2001) (26)
Mycobacterial nucleic acids in sarcoid lesions (1992) (26)
Humoral primary immune response in vitro in a homologous mouse system: replacement of fetal calf serum by a 2-mercaptoethanol or macrophage-activated fraction of mouse serum. (1977) (26)
Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A (1994) (26)
Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines. (1991) (26)
Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro (2004) (25)
Suppressive effect of lipid A partial structures on lipopolysaccharide or lipid A-induced release of interleukin 1 by human monocytes. (1990) (25)
CFU-C populations in blood and bone marrow of dogs after lethal irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells. (2009) (25)
Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro (1993) (25)
The use of reverse transcription polymerase chain reaction to analyse large numbers of mRNA species from a single cell. (1996) (25)
Antibody-induced modulation of CD26 surface expression. (1995) (24)
Functional and molecular characterization of a monoclonal antibody against human interleukin 2. (1986) (24)
CD34+ Hematopoietic Stem Cells Exert Accessory Function in Lipopolysaccharide-induced T Cell Stimulation and CD80 Expression on Monocytes (1999) (24)
Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen. (1988) (23)
Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells. (1992) (22)
Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release. (1991) (20)
Separation of human lymphocytes by free-flow electrophoresis. (1973) (20)
Induction of cytokines in mononuclear and vascular cells by endotoxin and other bacterial products. (1994) (20)
Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences. (1992) (19)
Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor. (1976) (19)
The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers. (2001) (18)
Lipid A, the immunostimulatory principle of lipopolysaccharides? (1990) (18)
Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. (1990) (18)
Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle. (1993) (17)
The Internalization Time Course of a Given Lipopolysaccharide Chemotype Does Not Correspond to Its Activation Kinetics in Monocytes (1999) (17)
Follicular dendritic cells and their role in HIV infection. (1992) (17)
Monocyte-T-cell interactions in pokeweed mitogen-activated cultures. (1990) (16)
Characterization of a platelet derived factor modulating phagocyte functions and cooperating with interleukin 1. (1989) (15)
Ligation of CD 40 Activates Interleukin 1 b-converting Enzyme ( Caspase-1 ) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1 b * (1997) (15)
FcR+ and FcR- monocytes differentially secrete monokines during pokeweed mitogen-induced T-cell-monocyte interactions. (1992) (14)
Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1-like reaction (1998) (14)
The Role of Cytokines in Monocyte Apoptosis (2000) (14)
Interleukin 1 and tumor necrosis factor: studies on the induction by lipopolysaccharide partial structures. (1989) (14)
In vitro generation of bacillus Calmette-Guérin-activated killer cells. (2000) (14)
Actin: a target of lipopolysaccharide-induced phosphorylation in human monocytes. (1997) (13)
An Fcγ receptor I (CD64)‐negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen‐activated CD4‐positive cytotoxic T cells (1997) (13)
Cytokines in inflammation (1998) (13)
Immunodiagnosis and Immunotherapy of Malignant Tumors (1979) (13)
Immunoglobulin production of human lymphocytes stimulated by Staphylococcus aureus Cowan I and pokeweed mitogen: differential effects of recombinant interleukin-2. (1986) (13)
Pokeweed mitogen activated suppressor T-cells preferentially reduce immunoglobulin secretion by differentiated B-lymphocytes. (1986) (13)
The effect of vitamin A on experimental immune thyroiditis. (1967) (11)
CD26 is not required for infection of the lymphoma cell line C8166 with HIV-1. (1994) (11)
B and T lymphocyte colony formation in agar: 2-mercaptoethanol-activated albumin can substitute for 2-mercaptoethanol. (1979) (11)
Enhancement of monocyte antimycobacterial activity by diethyldithiocarbamate (DTC). (1991) (11)
The repopulation of lymph nodes of dogs after 1200 R whole-body x-irradiation and intravenous administration of mononuclear blood leukocytes. (1976) (10)
Correlation between cytokinetically resting lymphocytes and bone marrow restoration: experiments using a discontinuous albumin gradient. (1973) (10)
Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy. (1997) (10)
Is platelet factor-4 a chemokine? (2000) (10)
Functional relationships of human T-lymphocytes and interleukins: I. Different accessory cell requirements of human T-lymphocyte subpopulations for generation of interleukin-2. (1982) (10)
Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor (1975) (9)
Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cells (1995) (9)
The effect of interleukin 2 on Fc-gamma receptor function of human monocytes requires specific intercellular interaction. (1989) (9)
An examination of the immune system of the duck (Anas platyrhynchos) for factors resembling some defined mammalian cytokines. (1993) (9)
Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells. (1985) (9)
Interleukin 1 and related cytokines. (1989) (9)
The role of monocytes in the induction and regulation of IFN-gamma production by lectin-activated human T lymphocytes. (1991) (9)
Immunoenzymatic assessment of interferon-γ in hodgkin and sternberg-reed cells (1990) (9)
Proliferation-associated Ki-67 protein is a target for autoantibodies in the human autoimmune disease systemic lupus erythematosus. (1998) (9)
The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. (2002) (8)
Apoptosis in monocytes. (1999) (8)
Bacterial Endotoxins: Relationships Between Chemical Structure and Biological Activity (1989) (8)
Association of IL-2 Production with the Expression of Dipeptidyl Peptidase IV (DPIV) on Human T Lymphocytes (1986) (8)
Effect of human recombinant interleukin 2 on natural killing of low density Percoll fraction cells. (1986) (8)
K cell activity of normal and chronic lymphocytic leukaemia lymphocytes: association with lymphocytes bearing receptors for human C3b. (1977) (8)
Immunoenzymatic assessment of interferon-gamma in Hodgkin and Sternberg-Reed cells. (1990) (8)
Regulation of neutrophil activation by proteolytic processing of platelet-derived alpha-chemokines. (1997) (8)
Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes (1978) (7)
Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion. (1981) (7)
Elimination of monocytes from cultures activated with recall antigens. (1995) (7)
Adjuvant intermittent chemoimmunotherapy for primary breast cancer: a prospective study with immunologic follow-up. (1982) (7)
CD26 (dipeptidyl peptidase i.v.) on human T lymphocytes does not mediate adhesion of these cells to endothelial cells or fibroblasts. (1998) (7)
In Vitro Cellular Cytotoxicity Against Human Bladder Carcinoma Cell Lines (1991) (7)
Immunological deficiency syndrome in non-identical twins: maintenance in a gnotobiotic state and attempts at treatment with transplants of bone marrow and foetal thymus. (1971) (7)
Effects of systemicin vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC) (1986) (7)
Transforming growth factor-beta 1 (TGF-beta 1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. (1994) (7)
Lissencephaly, abnormal lymph nodes, and T-cell deficiency in one patient. (1989) (7)
Definition of MLC specificities in the dog. (1975) (7)
One-stage stimulation of human T-lymphocyte colony-forming units (TL-CFU) in a micro agar culture in glass capillaries. (1979) (7)
Macrophages/monocytes require cell-to-cell contact in order to regulate the growth of a murine lymphoma cell line. (1979) (7)
Phase I evaluation of bestatin in patients bearing advanced solid tumors (1980) (6)
Cell-mediated lympholysis in dogs: studies of the cytotoxic mechanism. (1975) (6)
Disseminated mycobacterial histiocytosis due to M. fortuitum associated with helper T-lymphocyte immune deficiency (2004) (6)
Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2- and BCG-activated effector cells (2000) (6)
Hemopoietic and lymphopoietic split chimerism in severe combined immunodeficiency disease (SCID). (1979) (6)
Suppression of Staphylococcus aureus Cowan I-induced immunoglobulin synthesis in vitro: discrimination between the presence of suppressor T cell precursors and effectors. (1986) (6)
Histocompatibility testing in dogs. II. Leukocyte typing in relation to the mixed lymphocyte culture (MLC) reactivity. (2008) (6)
Rhesus incompatibility and aplastic anemia as the consequence of split chimerism after bone-marrow transplantation for severe combined immunodeficiency. (1980) (6)
[Bacterial endotoxins: relationship between chemical structure and biological effect]. (1993) (6)
Reduction of side effects of intravesical therapy with bacille Calmette-Guérin by pentoxifylline?--an in vitro approach. (2000) (5)
Cytokine production and proliferative capacity of infiltrating cells in various forms of leprosy. (1990) (5)
Book reviews (2004) (5)
Cytokines in mycobacterial infections: in vitro and ex vivo studies. (1995) (5)
Cytokines in inflammation. Joint Workshop of the Deutsche Gesellschaft für Immunologie (DGfI) and the Gruppo di Cooperazione in Immunologia (GCI) Assergi (L'Aquila, Italy), February 8-11, 1998. (1998) (5)
[Long-term substitution with platelets in patients with aplastic anemia and severe thrombocytopenia (author's transl)]. (1973) (5)
Tumor necrosis factor alpha and interleukin-1 beta in rejecting human liver grafts. (1991) (5)
Immunodiagnosis and immunotherapy of malignant tumors : relevance to surgery (1979) (5)
Effect of dexamethasone on mechanisms responsible for regulation of polyclonal B-cell response. (1989) (5)
In vitro effects of phytohemagglutinin and brain antigen on cell transfer of experimental autoimmune encephalomyelitis in Lewis rats. (1968) (5)
Promotion of L1210 tumour growth by macrophages. (1978) (5)
[Circulating immune complexes and NK activity in systemic lupus erythematosus]. (1984) (5)
Establishment and characterization of an Epstein-Barr virus transformed cell line with strong phagocytic activity. (1989) (5)
Detection of intracellular interleukin 2: evidence for novel immunologically related forms of the lymphokine. (1994) (5)
Detection of Mycobacterium leprae by three-primer PCR. (1994) (4)
Suppression of in vitro primary immune response by L1210 cells and their culture supernatant: evidence for cytotoxic effects. (1977) (4)
Strain Differences in the Liver Autoantibody Response of Inbred Mice (1969) (4)
Graft-versus-host reaction after blood transfusion in a patient with cellular immunodeficiency: The role of histocompatibility testing (1979) (4)
Stimulation of human T lymphocytes by lipopolysaccaride (LPS) in the presence of autologous and heterologous monocytes. (1998) (4)
rIL-2-activated killer cell generation is influenced by autologous TNF-alpha production. (1995) (4)
Stimulation of colony formation and growth factor production of human T lymphocytes by wheat germ lectin. (1982) (4)
Immunoenzymatic assessment of IL-1 beta mRNA by in situ hybridization using sulphonated probes. (1989) (3)
A phase I/II trial of recombinant interleukin-2 in AIDS/ARC: alterations of phenotypes of peripheral blood mononuclear cells. (1986) (3)
Binding characteristics of a monoclonal antibody against human IL-2 and its application for IL-2 measurement. (1986) (3)
Role of serum factors and adherent cells in cloning of human T lymphocytes in agar culture. (1979) (3)
Effect of Lymphocyte Stimulants on Specific Antibody Synthesis in vitro (1968) (3)
Within the spectral forms of leprosy cellbound CD30 cannot be regarded as an operational marker for the Th2‐like reaction (1996) (3)
[Current status of immunotherapy of malignant tumors]. (1979) (3)
An Fc gamma receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells. (1997) (3)
Quantitative and Functional Studies of Lymphocyte Subpopulations During Adjuvant Chemo(immuno)therapy in Patients with Breast Cancer (1979) (3)
Differential inhibition of IL-1 beta activities and receptor binding by monoclonal antibodies mapping within a discrete region of the protein. (1991) (3)
A new ultra-microculture system. I. Stimulation of human T lymphocytes by phytohemagglutinin (PHA). (1984) (3)
Interleukin 2 induces appearance of LGL/Leu11+/K562 lytic cells in Leu11- low density peripheral blood mononuclear cell population. (1987) (2)
Transplantation of allogeneic dog leukocytes into lethally irradiated matched or mismatched recipients [proceedings]. (1976) (2)
Interleukin 2 as an inducer of proliferation in Klebsiella-stimulated human B cells. (1989) (2)
CHEMOKINES Platelet Factor 4-Induced Neutrophil-Endothelial Cell Interaction : Involvement of Mechanisms and Functional Consequences Different From Those Elicited by Interleukin-8 By (1999) (2)
ADP-ribosylation: role in LPS-induced phosphorylation of two cytosolic proteins (p36/38) in monocytes. (1998) (2)
T-lymphocyte colony formation of murine spleen cells in a one-stage micro agar culture. (1981) (2)
Inhibition of interleukin-6 release and T-cell proliferation by synthetic mirror pseudo cord factor analogues in human peripheral blood mononuclear cells. (1993) (2)
Activation of human monocytes by interleukin 2: role of T lymphocytes. (1991) (2)
Transplantation of a patient with severe combined immunodeficiency (SCID) with bone marrow from the MLC identical donor: some immunobiological aspects [proceedings]. (1976) (2)
Colony growth of human T-lymphocyte colony forming units (TL-CFU) after X-irradiation. (1981) (2)
Large granular lymphocytes are central cells in the interleukin-2-dependent differentiation pathway of natural killer cells. (1987) (2)
Binding of interleukin 2 to target cells: determination of high and low affinity binding sites on T-lymphoblasts by differential dissociation. (1985) (2)
A CASE OF IMPAIRED CHEMOTAXIS AND LYMPHOCYTE TRANSFORMATION (1976) (2)
Lymphopoietic split chimerism in severe combined immunodeficiency after transplantation of cultured thymus epithelium. (1980) (2)
Histocompatibility testing in dogs. I. A semi-micro mixed lymphocyte culture (MLC) technique for histocompatibility matching in dogs. (1975) (2)
[Significnace of tumor-immunology tests in surgery]. (1979) (2)
Adjuvant intermittent chemo-immunotherapy of breast cancer. A prospective study. (1980) (2)
[Studies on the effect of nicotinic acid and adenosine monophosphate on skin and muscle circulation in healthy subjects and patients with peripheral circulatory disorders]. (1966) (1)
Augmentation of interleukin 2-activated cytotoxicity after treatment of cells with inhibitors of interferon production. (1991) (1)
Split chimerism in three patients suffering from severe combined immunodeficiency (SCID). (1980) (1)
Mycobacterium leprae DNA content, cellular and cytokine patterns in skin lesions of leprosy patients undergoing multidrug therapy (MDT). (1994) (1)
Interaction of human lymphocyte subpopulations with interleukin 2 (II-2). (1981) (1)
[The effect of parenteral nutrition on cellular immune status in patients with gastrointestinal cancer]. (1979) (1)
The role of helper monocytes in mitogenic activation of human T-lymphocyte subpopulations. (1982) (1)
[Immunological mechanisms of metastasis]. (1980) (1)
Adjuvant and suppressor activity of the polycation protamine hydrochloride in the primary immune response of mice. (1976) (1)
Functional and molecular characterization of a monoclonal antibody against the 165-186 peptide of human IL-1 beta. (1989) (1)
Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes. (1978) (1)
The effect of a methylhydrazine derivative on experimental immune thyroiditis in guinea pigs. (1966) (1)
Suppression ofStaphylococcus aureus CowanI-induced immunoglobulin synthesis invitro: discrimination between the presence ofsuppressor Tcell precursors andeffectors (1986) (1)
Possible Bithermic Pathomechanism in Cryoglobulinemic Vasculitis (1969) (1)
Biochemistry and cell biology of bacterial endotoxins MiniReview (1996) (1)
Immunological reconstitution of a patient with severe combined immunodeficiency with bone marrow from the MLC matched but HLA-incompatible mother [proceedings]. (1976) (1)
Induction of IL-1 by lipopolysaccharide (LPS) and its modulation by synthetic lipid A precursor Ia. (1990) (1)
Autologous Regulation of rIL-2-Activated Natural Killer Cells (1990) (1)
Contents, Vol. 62, 1979 (1979) (0)
Surface Expression Is Essential for Maintenance of Receptor -Glycosylation N 2 Glycoforms in Neutrophils: and Intracellular CXC-Chemokine Receptor Identification of Distinct Surface-Expressed (2000) (0)
Application of a new ultra-microculture system. II. Stimulation of human B lymphocytes. (1988) (0)
October 2002 Fellowships Grants and Awards (2002) (0)
Ultrastructure of lymphocytes and macrophages in the migration-inhibition test (MIT). (1972) (0)
induces monocyte differentiation into macrophages The CXC-chemokine platelet factor 4 promotes monocyte survival and (2013) (0)
Blast Transformation and DNA Synthesis in Lymphocyte Cultures from Patients with Aplastic Anaemia (1972) (0)
MYCOBACTERIUM LEPRAE DNA, CELLULAR AND CYTOKINE PATTERNS IN SKIN LESIONS OF PATIENTS WITH VARIOUS FORMS OF LEPROSY (1994) (0)
[Experimental studies on the delayed immunoreaction to insulin]. (1969) (0)
Fourth Annual Meeting of the European Association for the study of diabetes (1968) (0)
[Lymphopenic hypogammaglobulinemia in biovular twins: rearing during first year of life under germ-free gnotobiotic conditions]. (1971) (0)
Determination of α1-Antitrypsin with a Chromogenic Peptide Substrate Methodology and Clinical Application (1979) (0)
[Clinical significance of lymphocyte populations]. (1979) (0)
The germinal center: Another place for T-cell selection and maturation? (1997) (0)
Immunological Changes During a Perioperative Parenteral Hyperalimentation in Gastrointestinal Cancer (1979) (0)
25. Immumolgical deficiency syndrome in nonidentical twins: attempts at treatment with transplanlation of bone marrow and fetal thymus (1971) (0)
Mycobacteria-induced TNF and IL-10 formation by human macrophages: the role of MAP kinases (2000) (0)
Mycobacterial nucleic acids in sarcoid lesions. Authors' reply (1992) (0)
Cellular requirements for interleukin 1 induction with lipopolysaccharides (1988) (0)
Cell-mediated lympholysis: studies on the identification of the killer cell. (1974) (0)
[The C3 activating capacity in human serum--measured as monocyte mediated chemiluminescence]. (1984) (0)
Interleukin 2 binding capacity of human mononuclear leukocytes. (1986) (0)
[Changes of the peripheral venous tone in healthy persons and heart disease patients in stress]. (1966) (0)
Search for the Role of Immunotherapy with Corynebacterium Parvum Intrapleurally in Operable Bronchial Non-Small-Cell Carcinoma (1979) (0)
[Blastic transformation and DNA synthesis in lymphocyte cultures from patients with aplastic anemia (panmyelopathy)]. (1970) (0)
Chronic lymphoid leukemia: concentration of normal lymphocytes in the lymph. (1974) (0)
Preactivation and phenotype of monocytes have no influence on their elimination from culture by activated T lymphocytes. (1995) (0)
Factor 4 and Is Involved in Cell ActivationPlatelet Human Neutrophils Specifically Binds A Chondroitin Sulfate Proteoglycan on (1998) (0)
[Concentration of normal lymphocytes in lymph of chronic lymphatic leukemia patients]. (1973) (0)
Bone marrow transplantation for severe aplastic anemia: Ulm experience [proceedings]. (1978) (0)
RECEPTORS AND SIGNALING PATHWAYS FOR GRAM‐POSITIVE CELL WALL COMPOUNDS.: 676 (1997) (0)
Subject Index, Vol. 62, 1979 (1979) (0)
Structural requirements for interleukin 1 induction with lipopolysaccharides (1988) (0)
Lymphocyte populations in chronic lymphocytic leukemia. (1974) (0)
Mitogen-Activated Protein Kinase Activity Differentially Regulated at the Level of Formation by Human Macrophages Is and IL-10 α Mycobacteria-Induced TNF (2001) (0)
[Disturbed B-cell recirculation in chronic lymphadenosis]. (1973) (0)
1–14 Prélude: Macrophages in Inflammation / 15–35 Macrophages in Anti-Inflammation: Molecular Mechanisms / 36–46 Macrophages in Anti-Inflammation: Apoptosis / 47–56 Macrophages in Anti-Inflammation: Induction of Tolerance (2000) (0)
Their Impact on Neutrophil Functions -Thromboglobulin and β the CXC Chemokine Novel C-Terminally Truncated Isoforms of (2013) (0)
Role of an Immunoregulatory Serum Component in Human Mixed Lymphocyte Reaction (1979) (0)
Book Reviews (1912) (0)
[Behavior of lymphatic subpopulations under cytostatic therapy]. (1978) (0)
Split chimerism in severe combined immunodeficiency (1978) (0)
[Delayed hypersensitivity in vitro: possibilities for using the system in humans]. (1969) (0)
[The cellular immune status in normal subjects, patients with and without neoplasms]. (1978) (0)
[Bithermic complement activation in cryoglobulinemia]. (1968) (0)
CD14, An Innate Immune Receptor for Various Bacterial Cell Wall Components (2020) (0)
Infection of human monocyte-derived macrophages with Mycobacterium avium: MAP kinase activation is inversely correlated to bacterial survival in vitro (2000) (0)
Peptidoglycan monomer induces cytokine production in human mononuclear cells via CD14 (1997) (0)
[Quantitative and functional response of a lymphatic subpopulation during adjuvant intermittent chemo-immunotherapy in breast cancer]. (1978) (0)
Intravesical BEG-instillation therapy for superficial bladder cancer: A standard beneficial treatment beyond the understanding of its mode of action? (1997) (0)
[Immuno-deficiency states and the lungs (author's transl)]. (1974) (0)
[Measurement and immunocytological demonstration of interleukin-2 (IL-2) with the aid of a monoclonal antibody (BO-7)]. (1987) (0)
Induction and modulation of interleukin 1 production by defined partial structures of lipopolysaccharide. (1991) (0)
Migration Neutrophil Adhesion and Transendothelial Differentially Affect and Cross-Regulate Tissue-Activating Peptide III , and CXCL 4 Chemokine Ligand ( CXCL ) 7 , Connective Platelet-Derived Chemokines CXC (2002) (0)
Immunology and Immune Reactions in Malignant Lymphoma (1974) (0)
CellsCytokine Release of Activated Human T Platelet Factor 4 Inhibits Proliferation and and (2002) (0)
Book Reviews (1918) (0)
Migration Inhibitory Factor and Mitogenic Factor Produced by Antigen-Stimulated Human Lymphocytes (1971) (0)
Effects of colony-stimulating factors on cellular cytotoxicity (1997) (0)
Antigen-specific activation of human T-cells: The role of monocytes and monocyte subpopulations (1991) (0)
Cytokine production in human mononuclear cells induced by peptidoglycan monomer is CD14 dependent (1997) (0)
Immunotherapy of leukaemias: Present status and future prospects (1978) (0)
Subject Index Vol. 67, 1999 (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hans‐dieter Flad?

Hans‐dieter Flad is affiliated with the following schools:

New York University

Hans‐dieter Flad's Academic­Influence.com Rankings

Why Is Hans‐dieter Flad Influential?

Hans‐dieter Flad's Published Works

Published Works

What Schools Are Affiliated With Hans‐dieter Flad?

Hans‐dieter Flad's AcademicInfluence.com Rankings